Skip to content

For laboratory research use only. Not for human or veterinary consumption.

MYOGENX

Tirzepatide

GIP and GLP-1 receptor dual agonist

99.2% HPLCIdentity confirmedUK stock

Tirzepatide is a synthetic peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It is studied in metabolic research models.

Supplied lyophilised in a sterile glass vial. Purity is established by HPLC and identity confirmed by mass spectrometry, with both traces published on the batch certificate.

Tirzepatide, MYOGENX. GIP and GLP-1 receptor dual agonist.

Research use only. Not for human or veterinary use. We cannot provide guidance relating to human consumption, including dosage, protocols or administration, under any circumstances. MYOGENX operates strictly as a research supplier.

£50.00

In UK stock

Strength
SKU
MGX-TIR-20
Batch
MGX-2407-TIR
Dispatch
Same day before 15:00, Mon to Fri
Shipping
Free over £75.00

Batch verified

MGX-2407-TIR

Analysed by Janoshik Analytical. Published before this batch went on sale, and printed on the vial.

Read the certificate

Specification

The full record

Everything on the certificate, on the page. Nothing held back for after you have paid.

Chemical and handling specification for Tirzepatide
Purity99.2% by HPLC
CAS number2023788-19-2
Molecular weight4813.45 g/mol
Molecular formulaC225H348N48O68
FormatLyophilised powder in a sterile glass vial
AppearanceWhite lyophilised solid
Storage-20°C in a dry, dark, desiccated environment
Intended useLaboratory research only. Not for human or veterinary use.